Cytomegalovirus and Myocardial Infarction: Inflammatory Biomarkers
Author Information
Author(s): Xu Xinling, Silveira Angela, Lundman Pia, Rahbar Afsar, Söderberg-Nauclér Cecilia
Primary Institution: Karolinska Institutet, Stockholm, Sweden
Hypothesis
Does cytomegalovirus (CMV) seropositivity correlate with inflammatory and metabolic biomarkers in patients with myocardial infarction?
Conclusion
CMV seropositive patients after myocardial infarction showed higher levels of inflammatory markers IL-6 and PAI-1, and lower levels of MMP-3 compared to seronegative patients.
Supporting Evidence
- CMV seropositive patients had higher levels of PAI-1 and IL-6 compared to seronegative patients.
- CMV IgG levels were significantly lower in MI patients than in controls.
- CMV seropositivity was associated with increased proinsulin levels but not with diabetes diagnosis.
- Correlation analyses showed a weak positive correlation between CMV IgG levels and PAI-1 in MI patients.
Takeaway
This study found that people who had a virus called cytomegalovirus and had a heart attack had more signs of inflammation in their bodies than those who didn't have the virus.
Methodology
The study analyzed blood samples from 324 myocardial infarction survivors to measure various inflammatory and metabolic biomarkers and performed correlation analyses with CMV serostatus.
Potential Biases
The study may be influenced by the treatment effects of medications like aspirin and statins on CMV activity and inflammatory responses.
Limitations
The study is biased towards patients that have survived myocardial infarction, and not all biomarkers were measured for all patients, leading to missing values.
Participant Demographics
Participants were unselected survivors of a first-time myocardial infarction below age 60, with age- and sex-matched controls.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website